ALBANY, N.Y., March 08, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer, is scheduled to participate in a Q&A session at the Barclays Global Healthcare Conference on Thursday, March 16, 2017, at 9:00 a.m. ET. The conference will be held at the Loews Miami Beach Hotel in Miami, Fla.
A live audio and/or webcast and subsequent archived replay of AngioDynamics' session may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral
vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact:
AngioDynamics Inc.Caitlin Stefanik
(518) 795-1418
cstefanik@angiodynamics.com
Investor Relations Contacts:
FTI Consulting
Jim Polson
(312) 553-6730
Jim.Polson@fticonsulting.com,
Kotaro Yoshida
(212) 850-5690
Kotaro.Yoshida@fticonsulting.com
Media Contact:
FTI Consulting
Kimberly Ha
(212) 850-5612
kimberly.ha@fticonsulting.com
Source:
AngioDynamics
News Provided by Acquire Media